4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001055919-26-000003
Options or other derivatives
- Co-Chief Executive Officer acquired 11,232 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DUGGAN ROBERT W · Co-Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +11,232 | $8.76 | $98,392 | 11,232 | D |
Loading xslF345X05/wk-form4_1767747017.xml…